Financials

  • Market Capitalization 20.45 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
4603
TVGN
Tevogen Bio Holdings Inc. - Common Stock
4.92 USD-1.99%-2.77%-50.50%+303.28%20.60 M USD
4606
NXTC
NextCure, Inc. - Common Stock
5.68 USD-13.68%+226.44%+175.73%-56.64%20.52 M USD
4610
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.37 USD+4.87%-2.87%+0.42%+160.44%20.41 M USD
4617
LGVN
Longeveron Inc. - Class A Common stock
0.64 USD+3.23%-3.03%-18.99%+12.03%19.93 M USD

新闻